首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1402087

全球臉部注射劑市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

Global Facial Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年12月01日 | 出版商:

Value Market Research | 英文 235 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球臉部注射劑市場需求預計將從 2022 年的 115.9 億美元達到 2030 年近 320.1 億美元的市場規模，2023-2030 年研究期間CAGR為 13.54%。

臉部注射是指非手術美容治療，涉及將物質注射到臉部各個區域，以改善外觀、減少皺紋、恢復體積和恢復皮膚紋理。這些注射治療由合格的醫療專業人員（通常是皮膚科醫生或整形外科醫生）進行，以解決各種美學問題並實現所需的臉部改善。

市場動態

由於影響消費者偏好和化妝品行業的各種影響因素，臉部注射劑市場呈現成長趨勢。老化人口對年輕容貌的渴望推動了對臉部注射劑的需求，為皺紋、細紋和臉部體積損失提供解決方案。非手術治療因其侵入性極小和減少停機時間而受到歡迎，作為傳統手術的替代方案，推動了市場的擴張。注射技術的不斷進步、配方的改進和創新的給藥方法提高了產品的功效、安全性和耐用性，促進了更廣泛的接受。社群媒體和名人的影響極大地影響了消費者的看法，鼓勵更多的人考慮透過臉部注射來增強美觀。提高意識、減少恥辱感和個人化治療計劃可滿足不同的美學需求，使臉部注射更容易獲得。經濟因素、負擔能力選擇以及男性對整容手術日益成長的興趣進一步促進了市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球臉部注射劑市場的每個細分市場進行了包容性評估。臉部注射產業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲臉部注射市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。臉部注射劑市場的主要參與者包括 Ispen、Abbvie、Medytox Inc.、Merz GmbH and Co.、KGaA、Revance Therapeutics Inc.、Galderma、Sinclair Pharma。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：臉部注射公司的競爭格局

臉部注射劑市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Ispen

公司簡介
公司收入
產品
最近的發展

Abbvie

公司簡介
公司收入
產品
最近的發展

Medytox Inc.

公司簡介
公司收入
產品
最近的發展

Merz GmbH and Co. KGaA

公司簡介
公司收入
產品
最近的發展

Revance Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Galderma

公司簡介
公司收入
產品
最近的發展

Sinclair Pharma

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112985

The global demand for Facial Injectables Market is presumed to reach the market size of nearly USD 32.01 BN by 2030 from USD 11.59 BN in 2022 with a CAGR of 13.54% under the study period 2023 - 2030.

Facial injectables refer to non-surgical cosmetic treatments involving the injection of substances into various facial areas to enhance appearance, reduce wrinkles, restore volume, and rejuvenate skin texture. These injectable treatments are administered by qualified medical professionals, typically dermatologists or plastic surgeons, to address various aesthetic concerns and achieve desired facial enhancements.

MARKET DYNAMICS

The facial injectables market exhibits growth owing to various influential factors shaping consumer preferences and the cosmetic industry. An aging population's desire for youthful looks drives demand for facial injectables, offering solutions for wrinkles, fine lines, and facial volume loss. Non-surgical options' popularity, due to their minimal invasiveness and reduced downtime, fuels the market's expansion as accessible alternatives to traditional surgery. Continual advancements in injectable technologies, improved formulations, and innovative delivery methods enhance product efficacy, safety, and durability, fostering wider acceptance. Social media and celebrity influences significantly impact consumer perceptions, encouraging more individuals to consider facial injectables for aesthetic enhancements. Increased awareness, reduced stigma, and personalized treatment plans cater to diverse aesthetic needs, making facial injectables more accessible. Economic factors, affordability options, and rising male interest in cosmetic procedures further contribute to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of facial injectables. The growth and trends of facial injectables industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the facial injectables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Collagen & PMMA Microspheres
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Others

By Application

Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Others

By End-Use

MedSpas
Dermatology Clinics
Hospitals

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Facial Injectables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Facial Injectables market include Ispen, Abbvie, Medytox Inc., Merz GmbH and Co., KGaA, Revance Therapeutics Inc., Galderma, Sinclair Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . FACIAL INJECTABLES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Collagen & PMMA Microspheres Historic and Forecast Sales by Regions
5.5 Hyaluronic Acid (HA) Historic and Forecast Sales by Regions
5.6 Botulinum Toxin Type A Historic and Forecast Sales by Regions
5.7 Calcium Hydroxylapatite (CaHA) Historic and Forecast Sales by Regions
5.8 Poly-L-lactic Acid (PLLA) Historic and Forecast Sales by Regions
5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Facial Line Correction Historic and Forecast Sales by Regions
6.5 Lip Augmentation Historic and Forecast Sales by Regions
6.6 Face Lift Historic and Forecast Sales by Regions
6.7 Acne Scar Treatment Historic and Forecast Sales by Regions
6.8 Lipoatrophy Treatment Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY END-USE

7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 MedSpas Historic and Forecast Sales by Regions
7.5 Dermatology Clinics Historic and Forecast Sales by Regions
7.6 Hospitals Historic and Forecast Sales by Regions

8 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FACIAL INJECTABLES COMPANIES

9.1. Facial Injectables Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF FACIAL INJECTABLES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Ispen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbvie
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Medytox Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merz GmbH and Co. KGaA
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Revance Therapeutics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Galderma
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Sinclair Pharma
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments